Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Classement en actions #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Prix de l'action
$4.70
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.09M
Changement (1 jour)
-0.21%
Changement (1 an)
-70.63%
Pays
US
Échange Apimeds Pharmaceuticals US, Inc (APUS)

Catégorie

Historique des divisions d’actions pour Apimeds Pharmaceuticals US, Inc (APUS)
L’action Apimeds Pharmaceuticals US, Inc (symbole : APUS) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 17, 2026.
Une action APUS achetée avant le Aug 17, 2026 équivaudrait aujourd’hui à 0 actions APUS.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE